Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT07123961
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
- Lung-protective Ventilation
- Pediatric Acute Respiratory Distress Syndrome (PARDS)
- Ventilator Management
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Weeks - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- High Driving Pressure Mechanical Ventilation — OTHERA participant who is already invasively mechanically ventilated will be placed on "Pressure Control Ventilation" mode on an Evita V500 (Manufacturer: Dräger, Lübeck, Germany) ventilator if they are not already. The driving pressure will be set to 25 cmH2O (rate of pressure delivery). The Children's Hospital of Philadelphia (CHOP) PICU's standard of care regarding sedation, fluid management, ventilator weaning, and extubation readiness for invasively mechanically ventilated children will be adhered to for the duration of the study. An Enlight 2100 Electrical Impedance Tomography (EIT) Device (Manufacturer: Timpel) strap will be placed across the participant's chest up to four times throughout the study for a few hours to image the aeration in the lungs.
- Low Driving Pressure Mechanical Ventilation — OTHERA participant who is already invasively mechanically ventilated will be placed on "Pressure Control Ventilation" mode on an Evita V500 (Manufacturer: Lübeck, Germany) ventilator if they are not already. The driving pressure will be set to 15 cmH2O (rate of pressure delivery). CHOP PICU's standard of care regarding sedation, fluid management, ventilator weaning, and extubation readiness for invasively mechanically ventilated children will be adhered to for the duration of the study. An Enlight 2100 (EIT) Device (Manufacturer: Timpel) strap will be placed across the participant's chest up to four times throughout the study for a few hours to image the aeration in the lungs.
Study Details
Acute respiratory distress syndrome (ARDS) is a serious and potentially life-threatening lung condition that can affect children. Currently, ventilator settings commonly used in treatment are based on approaches developed for adults, and it remains unclear whether these settings are equally effective for children. Because children's bodies respond differently than adults', it is important to determine the most effective ventilator strategies specifically for pediatric patients. This study will compare two different ventilator approaches in children with ARDS to identify which method provides the greatest benefit. The findings will also help inform the design of a larger study in the future.
Key Dates
- Start date
- Nov 7, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2029
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: High Driving Pressure Mechanical VentilationA participant who is already on the breathing machine will have the driving pressure set to 25 cmH2O (rate of pressure delivery). All other standard clinical care for this participant will stay the same based on what their clinical team chooses to do.
- Active Comparator: Low Driving Pressure Mechanical VentilationA participant who is already on the breathing machine will have the driving pressure set to 15 cmH2O (rate of pressure delivery). All other standard clinical care for this participant will stay the same based on what their clinical team chooses to do.
Primary Outcome Measure
Sustained Resolution of Hypoxemia [ Time Frame: Up to 672 hours ]
Central Contacts
- Helena Wiatrowski, B.A.7818123947
- Stephen Famularo III, B.A.412-478-7643
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Stephen Famularo Nadir Yehya, MD, MSCE (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
Related Studies
- Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDSEnrolling By Invitation · University of Pennsylvania · Philadelphia, Pennsylvania
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: ParidiprubartPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: VilobelimabPHASE2 · Recruiting · PPD Development, LP · Birmingham, Alabama